
Danaher Corporation (DHR) received a 55% rating from Validea's guru fundamental report, applying the Motley Fool's Small-Cap Growth Investor model, a score significantly below the 80-90% threshold for investor interest. While DHR passed several fundamental criteria including profit margin and cash flow, it failed on key growth and valuation metrics such as relative strength, sales and EPS growth comparison, and its P/E to growth ratio, indicating it does not align well with the characteristics sought by this specific growth-focused strategy despite its large-cap status.
Danaher Corporation (DHR) receives a suboptimal rating of 55% based on Validea's application of the Motley Fool Small-Cap Growth Investor model, a score significantly below the 80% threshold considered indicative of strategic interest. This assessment, reflected in a moderately negative sentiment score of -0.5 for the ticker, reveals a dichotomy in the company's profile. On one hand, DHR demonstrates fundamental operational strengths, passing criteria for profit margin, cash flow from operations, R&D spending, and effective management of working capital, including inventory and accounts receivable. It also shows positive insider holdings. However, the analysis flags critical weaknesses in areas crucial for a growth thesis, with failures on key metrics such as relative strength, year-over-year sales and EPS growth comparison, and profit margin consistency. Furthermore, the stock fails on valuation, as indicated by its P/E to growth ("The Fool Ratio"), and exhibits a potential structural weakness with a failing score on its long-term debt-to-equity ratio. The fact that DHR is a large-cap stock being measured against a small-cap model suggests a potential framework mismatch, but the results nonetheless point to a lack of current growth momentum and an unattractive valuation from this specific strategic perspective.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment